Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 May 2018
At a glance
- Drugs Adalimumab (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
- Acronyms Harmony
- Sponsors AbbVie
- 24 Apr 2018 Planned End Date changed from 31 Dec 2018 to 31 Jul 2019.
- 24 Apr 2018 Planned primary completion date changed from 31 Dec 2018 to 31 Jul 2019.
- 27 Nov 2017 Status changed from recruiting to active, no longer recruiting.